184 related articles for article (PubMed ID: 30639280)
41. Design of non-standard insulin analogs for the treatment of diabetes mellitus.
Pandyarajan V; Weiss MA
Curr Diab Rep; 2012 Dec; 12(6):697-704. PubMed ID: 22983891
[TBL] [Abstract][Full Text] [Related]
42. The Relevance of Clinical Pharmacology Studies of Basal Insulins to Primary Care.
Reid TS; White J; Meneghini L
J Fam Pract; 2019 Jan; 68(1 Suppl):. PubMed ID: 30677105
[TBL] [Abstract][Full Text] [Related]
43. Nasal absorption of mixtures of fast-acting and long-acting insulins.
Pillion DJ; Fyrberg MD; Meezan E
Int J Pharm; 2010 Mar; 388(1-2):202-8. PubMed ID: 20080164
[TBL] [Abstract][Full Text] [Related]
44. [New Insulins for Type 1 Diabetes treatment].
Rumié Carmi HK; Domínguez-Menéndez G; Araya M; Martínez-Aguayo A
Andes Pediatr; 2023 Jun; 94(3):278-285. PubMed ID: 37909930
[TBL] [Abstract][Full Text] [Related]
45. Cross-reactivity of three recombinant insulin analogs with five commercial insulin immunoassays.
Owen WE; Roberts WL
Clin Chem; 2004 Jan; 50(1):257-9. PubMed ID: 14709671
[No Abstract] [Full Text] [Related]
46. Urinary detection of rapid-acting insulin analogs in healthy humans.
Judák P; Coppieters G; Lapauw B; Van Eenoo P; Deventer K
Drug Test Anal; 2020 Nov; 12(11-12):1629-1635. PubMed ID: 32386349
[TBL] [Abstract][Full Text] [Related]
47. Performance evaluation and cross-reactivity from insulin analogs with the ARCHITECT insulin assay.
Moriyama M; Hayashi N; Ohyabu C; Mukai M; Kawano S; Kumagai S
Clin Chem; 2006 Jul; 52(7):1423-6. PubMed ID: 16690737
[TBL] [Abstract][Full Text] [Related]
48. Ultra-Rapid-Acting Insulins: How Fast Is Really Needed?
Wong EY; Kroon L
Clin Diabetes; 2021 Oct; 39(4):415-423. PubMed ID: 34866783
[TBL] [Abstract][Full Text] [Related]
49. Structural principles of insulin formulation and analog design: A century of innovation.
Jarosinski MA; Dhayalan B; Chen YS; Chatterjee D; Varas N; Weiss MA
Mol Metab; 2021 Oct; 52():101325. PubMed ID: 34428558
[TBL] [Abstract][Full Text] [Related]
50. Concentration and Chemical Stability of Commercially Available Insulins: A High-Resolution Mass Spectrometry Study.
Baechler F; Stettler C; Vogt B; Bally L; Groessl M
Diabetes Technol Ther; 2020 Apr; 22(4):326-329. PubMed ID: 32031881
[TBL] [Abstract][Full Text] [Related]
51. Long-acting basal insulin analogs: latest developments and clinical usefulness.
Mavrogiannaki AN; Migdalis IN
Ther Adv Chronic Dis; 2012 Nov; 3(6):249-57. PubMed ID: 23342239
[TBL] [Abstract][Full Text] [Related]
52. The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus.
Giorgino F; Battelino T; Bergenstal RM; Forst T; Green JB; Mathieu C; Rodbard HW; Schnell O; Wilmot EG
J Diabetes Sci Technol; 2023 Nov; ():19322968231204584. PubMed ID: 37937585
[TBL] [Abstract][Full Text] [Related]
53. Insulin stacking versus therapeutic accumulation: understanding the differences.
Heise T; Meneghini LF
Endocr Pract; 2014 Jan; 20(1):75-83. PubMed ID: 24013982
[TBL] [Abstract][Full Text] [Related]
54. Quantification of Insulin Analogs by Liquid Chromatography-High-Resolution Mass Spectrometry.
Fatica EM; Larkey NE; Singh RJ
Methods Mol Biol; 2022; 2546():217-226. PubMed ID: 36127592
[TBL] [Abstract][Full Text] [Related]
55. The Evolution of Insulin and How it Informs Therapy and Treatment Choices.
Hirsch IB; Juneja R; Beals JM; Antalis CJ; Wright EE
Endocr Rev; 2020 Oct; 41(5):733-55. PubMed ID: 32396624
[TBL] [Abstract][Full Text] [Related]
56. Top-down mass spectrometric immunoassay for human insulin and its therapeutic analogs.
Nedelkov D; Niederkofler EE; Oran PE; Peterman S; Nelson RW
J Proteomics; 2018 Mar; 175():27-33. PubMed ID: 28780057
[TBL] [Abstract][Full Text] [Related]
57. Insulin analogs and cancer.
Sciacca L; Le Moli R; Vigneri R
Front Endocrinol (Lausanne); 2012; 3():21. PubMed ID: 22649410
[TBL] [Abstract][Full Text] [Related]
58. Insulin analogs with improved pharmacokinetic profiles.
Brange J; Vølund A
Adv Drug Deliv Rev; 1999 Feb; 35(2-3):307-335. PubMed ID: 10837704
[TBL] [Abstract][Full Text] [Related]
59. [New insulin analogs. Its use in patients with chronic kidney disease].
Litwak LE
Medicina (B Aires); 2018; 78(1):60-61. PubMed ID: 29360083
[No Abstract] [Full Text] [Related]
60. Confusion Regarding Duration of Insulin Action: A Potential Source for Major Insulin Dose Errors by Bolus Calculators.
Walsh J; Roberts R; Heinemann L
J Diabetes Sci Technol; 2014 Jan; 8(1):170-178. PubMed ID: 24876553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
